TB-500 Fragment 17-23

TB-500 Fragment 17–23 — Research Use Only

TB-500 Fragment 17–23 is a synthetic peptide segment derived from Thymosin Beta-4, corresponding to amino acids 17 through 23 of the parent sequence. This specific fragment is supplied for experimental and analytical research involving peptide segmentation, structural evaluation, and controlled in vitro investigations.

Fragment peptides such as TB-500 17–23 are commonly utilized in laboratory research to study sequence-specific interactions, peptide stability, and structure-function relationships under controlled conditions.

Product Specifications

• Peptide Name: TB-500 Fragment 17–23

• Parent Peptide: Thymosin Beta-4 (TB-500)

• Amino Acid Range: 17–23

• Purity: ≥ 99% (HPLC verified)

• Form: Lyophilized powder

• Appearance: White to off-white powder

Intended Research Applications

✔ Peptide sequence and fragment analysis
✔ Structure-function research
✔ In vitro experimental models
✔ Analytical and reference studies

Applications listed are for informational purposes only and do not imply approved or intended medical use.

Storage & Handling

• Store at ≤ −20 °C for long-term stability

• Protect from moisture, heat, and direct light

• Handle using appropriate laboratory PPE

• Reconstitute and dispose of according to institutional laboratory protocols

Regulatory & Safety Disclaimer

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

This product is sold strictly as a research chemical. It is not intended for human use, therapeutic use, diagnostic use, or veterinary use. This compound has not been evaluated, approved, or licensed by Health Canada, the FDA, or any other regulatory authority.

By purchasing this product, the buyer acknowledges that it will be handled only by qualified professionals in a laboratory setting and assumes full responsibility for compliance with all applicable Canadian laws, regulations, and institutional guidelines.